ABCZF
Price
$22.25
Change
-$0.00 (-0.00%)
Updated
Sep 27 closing price
ANEB
Price
$2.05
Change
+$0.09 (+4.59%)
Updated
Sep 27 closing price
40 days until earnings call
Ad is loading...

ABCZF vs ANEB

Header iconABCZF vs ANEB Comparison
Open Charts ABCZF vs ANEBBanner chart's image
Abcam
Price$22.25
Change-$0.00 (-0.00%)
Volume$4K
CapitalizationN/A
Anebulo Pharmaceuticals
Price$2.05
Change+$0.09 (+4.59%)
Volume$9.63K
CapitalizationN/A
View a ticker or compare two or three
ABCZF vs ANEB Comparison Chart
Loading...
VS
ABCZF vs. ANEB commentary
Sep 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCZF is a Hold and ANEB is a Hold.

COMPARISON
Comparison
Sep 29, 2024
Stock price -- (ABCZF: $22.25 vs. ANEB: $1.81)
Brand notoriety: ABCZF and ANEB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCZF: 100% vs. ANEB: 353%
Market capitalization -- ABCZF: $5.12B vs. ANEB: $53.16M
ABCZF [@Biotechnology] is valued at $5.12B. ANEB’s [@Biotechnology] market capitalization is $53.16M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.37B to $0. The average market capitalization across the [@Biotechnology] industry is $3.01B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCZF’s FA Score shows that 1 FA rating(s) are green whileANEB’s FA Score has 0 green FA rating(s).

  • ABCZF’s FA Score: 1 green, 4 red.
  • ANEB’s FA Score: 0 green, 5 red.
According to our system of comparison, ABCZF is a better buy in the long-term than ANEB.

Price Growth

ABCZF (@Biotechnology) experienced а 0.00% price change this week, while ANEB (@Biotechnology) price change was -10.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.80%. For the same industry, the average monthly price growth was +5.34%, and the average quarterly price growth was -8.06%.

Reported Earning Dates

ANEB is expected to report earnings on Nov 08, 2024.

Industries' Descriptions

@Biotechnology (+3.80% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
ABCZF($5.12B) has a higher market cap than ANEB($53.2M). ABCZF YTD gains are higher at: 0.000 vs. ANEB (-25.207).
ABCZFANEBABCZF / ANEB
Capitalization5.12B53.2M9,626%
EBITDAN/AN/A-
Gain YTD0.000-25.207-
P/E Ratio1770.50N/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
ABCZF: Fundamental Ratings
ABCZF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
70
SMR RATING
1..100
87
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.14-0.28
-1.20%
GameStop Corp
TSLA210.60-3.51
-1.64%
Tesla
SPY552.08-11.60
-2.06%
SPDR® S&P 500® ETF Trust
AAPL222.77-6.23
-2.72%
Apple
BTC.X57431.023000-1681.457000
-2.84%
Bitcoin cryptocurrency

ABCZF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCZF has been loosely correlated with ASMB. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCZF jumps, then ASMB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCZF
1D Price
Change %
ABCZF100%
N/A
ASMB - ABCZF
41%
Loosely correlated
-2.64%
APLS - ABCZF
36%
Loosely correlated
-0.26%
NKTX - ABCZF
34%
Loosely correlated
-3.01%
ANEB - ABCZF
27%
Poorly correlated
-5.73%
SPRC - ABCZF
27%
Poorly correlated
-7.25%
More

ANEB and

Correlation & Price change

A.I.dvisor tells us that ANEB and ALDX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANEB and ALDX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANEB
1D Price
Change %
ANEB100%
-5.73%
ALDX - ANEB
30%
Poorly correlated
+0.61%
ABCZF - ANEB
27%
Poorly correlated
N/A
ASMB - ANEB
25%
Poorly correlated
-2.64%
PMVP - ANEB
24%
Poorly correlated
+0.64%
TNGX - ANEB
22%
Poorly correlated
-7.61%
More